Seeking Alpha

  Urologix, Inc. - OTCQB

11/25/2014, 5:56 PM ET
  • Jim Van Meerten | Send Message 8 May 2011

    ULGX - 96% Barchart technical buy signal - 17 new highs and up 25.00% in the last month-Relative Strength Index 69.11% and rising
      ULGX vs. ETF Alternatives
      Company Description
      Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from non-cancerous prostate enlargement also known as benign prostatic hyperplasia (BPH).